Table 1.
Ref., author | Number of patients | Therapy | Follow-up | Outcome | ER status evaluated |
---|---|---|---|---|---|
[13] Fentiman et al. | 164 | Radical mastectomy or tamoxifen 20 mg daily | Median of 10 years | OS HR (95% CI) 1.11 (0.75–1.65) PFS HR (95% CI) 0.55 (0.39–0.77) |
No |
[14] Kenny et al. | 131 | Wedge mastectomy or tamoxifen 40 mg daily | Median of 5 years | OS HR (95% CI) 1.06 (0.59–1.92) PFS not calculated |
No |
[15, 16] Gazet et al. | 200 | Mastectomy or tamoxifen 20 mg daily | 6 years | OS HR (95% CI) 0.75 (0.44–1.26) PFS not calculated |
No |
[5] Chakrabati et al. | 131 | Wedge mastectomy or tamoxifen 20 mg daily | 20 years | OS P = 0.4457 PFS P = <0.001 |
No |
ER oestrogen receptor, OS overall survival, HR hazard ratio, CI confidence interval, PFS progression-free survival